Health
A blood-based approach could enable personalized immunotherapy without the need for a tumor biopsy
In a study published in Cancer Discovery , cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells.
AI Summary
A study in Cancer Discovery identified cancer neoantigens and neoantigen‑specific T cells using circulating tumor DNA and immune cells from patient blood samples. The research was led by senior author Alena Gros, Ph.D., group leader of the Tumor Immunology and Immunotherapy Group at the Vall d’Hebron Institute of Oncology in Spain.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Fractionated radiosurgery reduces recurrence after surgery for brain metastases, may improve survivalContinue reading
- The hidden switch behind one of the biggest paradoxes in aging muscleContinue reading
- She Left After Waiting Hours in the Emergency Room. The ER Billed Her Anyway.Continue reading
- She’s spent two decades talking to parents who don’t vaccinate their children. Here’s what she’s learnedContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow